West Pharmaceutical Services WST Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by West Pharmaceutical Services in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: West Pharmaceutical Services’s 10-Q, filed July 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about West Pharmaceutical Services's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is West Pharmaceutical Services's total current liabilities?
- West Pharmaceutical Services (WST) reported total current liabilities of $640.5M in Q2 2026.
- How has West Pharmaceutical Services's total current liabilities changed year-over-year?
- West Pharmaceutical Services's total current liabilities increased by 5.9% year-over-year, from $604.6M to $640.5M.
- What is the long-term trend for West Pharmaceutical Services's total current liabilities?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's total current liabilities has grown at a 5.4% compound annual growth rate (CAGR), from $503.4M to $654.9M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.